2021-11-02T09:02:43-05:00 2020-12-31 131655065 LUTZ AND CARR CPAS LLP 551 FIFTH AVENUE SUITE 400 NEW YORK NY 10176 990 2020-01-01 204796293 MIGRAINE RESEARCH FOUNDATION INC MIGR 2129882743 1 GRACIE SQUARE NEW YORK NY 10028 CATHY GLASER PRESIDENT 2129882743 2021-08-13 1 CATHY GLASER 999009999 FREDERICK MARTENS P00298107 2126972299 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z CATHY GLASER 1 GRACIE SQUARE NEW YORK NY 10028 902355 0 X WWW.MIGRAINERESEARCHFOUNDATION.ORG X 2006 NY MRF HELPS MIGRAINE SUFFERERS BY FUNDING INNOVATIVE SCIENTIFIC RESEARCH GRANTS. 4 4 2 9 0 0 683779 288667 0 0 30277 16415 0 0 714056 305082 518469 8000 0 0 263455 152029 0 0 16375 115321 95603 897245 255632 -183189 49450 1918705 1534956 1124752 553575 793953 981381 MRF RAISES MONEY TO FUND INNOVATIVE MIGRAINE RESEARCH GRANTS TO FURTHER THE UNDERSTANDING OF THE CAUSES OF MIGRAINE, TO DEVELOP BETTER TREATMENTS, AND ULTIMATELY, TO CURE AND PREVENT MIGRAINE. MRF ALSO PROVIDES INFORMATION AND RESOURCES FOR SUFFERERS. 0 0 180374 8000 MRF SEED MONEY GRANTS PROGRAMMRF AWARDS SEED MONEY GRANTS OF UP TO $50,000 TO RESEARCHERS FOR BASIC AND CLINICAL SCIENTIFIC RESEARCH INTO THE CAUSES AND BETTER TREATMENT OF MIGRAINE. THIS IS AN ONGOING PROGRAM. 180374 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 4 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 4 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 NY X LISA INFANTINO 9147149459 158 WEST 15TH STREET 3C NEW YORK NY 10011 CATHY GLASER DIRECTOR/PRESIDENT 30.00 X X 0 0 0 STEPHEN SEMLITZ CHAIRMAN/VICE PRESIDENT 3.00 X X 0 0 0 BRIAN J DUFFY DIRECTOR 0.50 X 0 0 0 FREDERICK GODLEY DIRECTOR 0.50 X 0 0 0 RONALD S TAUBER DIRECTOR 0.50 X 0 0 0 SAMUEL L YATES TO MAY 2020 COO/SECRETARY/TREASURER 40.00 X 51548 0 4090 LISA INFANTINO SECRETARY/TREASURER 40.00 X 82538 0 7572 134086 0 11662 0 0 0 0 0 500 288167 288667 9162 9162 604526 597273 7253 7253 7253 0 500 0 0 305082 0 0 16415 8000 8000 140123 105092 26239 8792 11906 8930 2262 714 1000 750 190 60 7233 7233 500 500 8264 2251 5833 180 4487 3365 853 269 328 246 62 20 61051 45788 11600 3663 655 492 124 39 471 354 89 28 3210 2408 609 193 OTHER EXPENSES 4430 872 3487 71 FUNDRAISING EVENTS 2250 2250 PAYROLL SERVICE FEES 1326 994 252 80 STATE REGISTRATION FEES 265 199 50 16 133 133 255632 180374 58883 16375 44441 56390 1201258 1473584 46523 0 117 117 3665 3420 27603 27131 943 472 606641 0 15117 973 1918705 1534956 20860 12293 1103892 541282 1124752 553575 X 404867 304282 389086 677099 793953 981381 1918705 1534956 X 49450 -9368 147346 X 0 1 X 1 0 X 877722 883307 737126 683779 288667 3470601 877722 883307 737126 683779 288667 3470601 1762918 1707683 3030 7015 18056 30277 9162 67540 4203 4203 3542344 0.48210 0.51890 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 1 500 0 0 0 500 0 PART II-B, LINE 1: SUPPORT FOR ALLIANCE FOR HEADACHE DISORDERS ADVOCACY, A GROSS-ROOTS LOBBYING GROUP WORKING TO OBTAIN MORE FEDERAL FUNDING FOR HEADACHE RESEARCH. 23201 22729 472 4402 4402 0 472 443060 -9368 147346 137978 305082 0 305082 255632 0 255632 0 255632 PART XI, LINE 2D - OTHER ADJUSTMENTS: REVERSAL OF PRIOR YEAR GRANT RECEIVABLE -40,350. CANCELLATION OF PRIOR YEAR GRANTS 187,696. 1 CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE JJN5-01 CLEVELAND OH 44195 912153073 501(C)(3) 8000 MIGRAINE RESEARCH 1 0 PART I, LINE 2: DIRECT COMMUNICATION BY PHONE AND EMAIL WITH THE PRINCIPAL INVESTIGATOR ABOUT RESEARCH PROGRESS THROUGHOUT THE GRANT TERM. FINAL PAYMENT OF GRANT AWARD IS CONTINGENT UPON RECEIPT OF A FINAL SCIENTIFIC PROGRESS REPORT AND A FINAL BUDGET REPORT. GRANTS ARE AWARDED TO RESEARCH INSTITUTIONS, NOT INDIVIDUAL RESEARCHERS. BEFORE MONEY IS DISPERSED, A FORMAL GRANT AGREEMENT IS EXECUTED BY MRF, THE RESEARCH INSTITUTION, AND THE PRINICPAL INVESTIGATOR. FORM 990, PART VI, SECTION A, LINE 2 STEPHEN SEMLITZ, BOARD CHAIRMAN, AND CATHY GLASER, BOARD MEMBER AND PRESIDENT HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF FORM 990 PREPARED BY THE ORGANIZATION'S INDEPENDENT ACCOUNTANTS IS REVIEWED IN DETAIL BY THE CHIEF OPERATING OFFICER. KEY QUESTIONS AND ANSWERS ARE REVIEWED BY THE PRESIDENT. THE FULL DRAFT IS ALSO SENT TO THE BOARD OF DIRECTORS FOR THEIR REVIEW AND COMMENTS PRIOR TO FILING THE FORM. FORM 990, PART VI, SECTION B, LINE 12C ALL OFFICERS AND DIRECTORS ARE REQUIRED ANNUALLY TO DISCLOSE ANY CONFLICT OF INTEREST BETWEEN SERVING AS AN OFFICER OR DIRECTOR OF MRF AND ANY OTHER ACTIVITY. THIS IS DONE AT THE ANNUAL MEETING OF THE BOARD OF DIRECTORS. TO DATE, THERE HAVE BEEN NO SUCH CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15A BEFORE COMPENSATION FOR THE CHIEF OPERATING OFFICER/SECRETARY/TREASURER WAS DETERMINED, COMPARABILITY DATA AND NONPROFIT EMPLOYMENT AGENCIES WERE CONSULTED. THE COMPENSATION WAS REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS. THIS WAS LAST DONE AT THE ANNUAL MEETING ON NOVEMBER 14, 2019. THERE WERE NO CHANGES IN 2020. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES THESE DOCUMENTS AVAILABLE UPON REQUEST IN THE CORPORATE OFFICE. FORM 990, PART XI, LINE 9: REVERSAL OF PRIOR YEAR GRANT RECEIVABLE -40,350. CANCELLATION OF PRIOR YEAR GRANTS AWARDED 187,696.